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license (http://creativecommons.org/Summary Mechanisms and treatment of wear particle induced prosthetic aseptic loosening
remain under investigation, as current animal models are not yet entirely favourable for re-
searches because of individual differences or particle count differences. A new rat model of
self-control continuous intramedullary infusion of ultra-high molecular weight polyethylene
particles by osmotic pumps has been established in order to provide a more reliable model
without the limitations mentioned above. Ten male SpragueeDawley rats were used in this
present study. A Kirschner wire and a hollow needle were placed into the medullary cavity
of each femur. Two osmotic pumps containing different materials were implanted in the back
of the rats, and the polyvinyl tubing connected with each side of the pumps was led subcuta-
neously to the knee joint and connected to the exposed needle. Radiological examination, his-
tological analysis, tartrate-resistant acid phosphatase staining, immunohistochemistry, and
biomechanical evaluation were performed 6 weeks after surgery. The mean optical density
of the left femurs (control side) was 199.43  62.36, whereas that of right femurs (treatment
side) was 164.98  26.47 (p < 0.05). The treatment side presented thinner new bone and more
obvious interface membrane compared with the control side. There was a marked reduction in
tartrate-resistant acid phosphataseþ cells (11.1  2.5) in the control side in comparison with
the treatment side (21.3  3.9; p < 0.05). The integral optical density of the receptor activatorer@uni-duisburg-essen.de (C. Wedemeyer).
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50 R.-f. Ma et al.of the nuclear factor-kB protein in the control side (9800.4  1553.6) was less than that in the
treatment side (32351.4  3916.3; p < 0.05). The pull-out force was 1.14  0.08 N in the con-
trol side and 0.66  0.14 N in the treatment side (p < 0.05). Continuous infusion of ultra-high
molecular weight polyethylene particles into the rat bone-implant interface simulated the
clinical scenario of local polymer wear particle generation and delivery in humans.
Copyrightª 2013, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Approximately 10% of total joint replacement (knee and
hip) surgeries are revision procedures, performed primarily
because of wear particle-associated osteolysis and aseptic
loosening [1,2]. Wear particles, especially ultra-high mo-
lecular weight polyethylene (UHMWPE) generated by shear
stress and friction forces, can cause osteolysis by pene-
trating the articular cavity and entering the newly formed
capsule by means of phagocytosis [3].
Classical animal models are an important tool in the
investigation of the biological processes involved in wear
particle-induced osteolysis [4e10]. However, these con-
ventional studies used a single injection or repeated in-
jections of a high concentration of particles, which may not
be representative for the situation in the human body. In
the clinical setting, wear debris is generated continuously
rather than periodically [11]. In order to overcome this
obstacle, Kim et al. [11] developed a rat model in which
high-density polyethylene particles were continuously
infused into the knee joint cavity using an osmotic pump.
However, a self-control study, which can largely eliminate
individual differences between animals, was not carried
out, and the number of particles actually infused into the
joint space was not quantified. Therefore, it is necessary to
establish an in vivo model for investigation of self-control
osteolysis and the relationship between osteolysis and the
quantification of infused particles by continuous infusion of
wear particles. Such animal models mimicking the patho-
physiology in the human body are needed to better inves-
tigate the mechanisms and treatment options of aseptic
loosening. Classical skull dissolution mouse models are
limited as they use particles without an implant. In other
conventional models with both particles and implants, in-
dividual differences or particle count differences cannot be
eliminated which weakens the comparability and reli-
ability. In this study we developed a promising self-control
rat model in order to overcome these problems and provide
a controllable, quantifiable research tool. The model was
developed that involved the continuous infusion of
UHMWPE into each side of rat knee joints. Histomorpho-
logical changes, protein expression, and biomechanical
fixation strength related to osteolysis were analysed.Materials and methods
Animals
Ten male SpragueeDawley rats (provided by Laboratory
Animal Center, Sun Yat-sen University. Age: 10 weeks,weight: 340  10 g) were used. The animals were housed in
specific pathogen-free rooms for at least 1 week to allow
acclimatization, and then maintained in the specific
pathogen-free environment throughout the experimental
period. All experimental procedures involving animals were
in accordance with the Guide for the Care and Use of
Laboratory Animals (NIH publications Nos. 80-23, revised
1996). The animal experiment was approved by the uni-
versity’s ethics committee and was performed according to
the institutional ethical guidelines for animal experiments.
Preparation of particles
As in our previous study, commercially available pure
UHMWPE particles (Ceridust VP 3610) were provided by
Clariant (Gersthofen, Germany) [4,12,13]. More than 34% of
the particles were smaller than 1 mm, with a mean particle
size (given as equivalent circle diameter) of 1.74  1.43 mm
(range 0.05e11.06). For decontamination of endotoxins,
particles were washed twice in 70% ethanol at room tem-
perature for 24 h. Testing for endotoxins using a quantita-
tive limulus amoebocyte lysate assay (Charles River,
Margate, Kent, UK) at a detection level of <0.25 EU/mL was
negative. The particles were washed in phosphate-buffered
saline and then dried in a desiccator. For the continuous
infusion of high-density UHMWPE particles into rat knee
joints, an osmotic pump (Durect Corporation, Cupertino,
CA, USA) was used. The osmotic pump was filled with 200 mL
100% rat serum containing high-density UHMWPE particles
(1.0  1010 particles), and was implanted subcutaneously in
the backs of the rats.
Surgical procedures
General anaesthesia was induced by 10% chloral hydrate.
All the rats received bilateral hollow distal femoral
Kirschner wire implants. Using a sterile technique, the
intercondylar notch of the right distal femur (treatment
side) was exposed through a medial parapatellar approach.
A 23-gauge needle was used to manually drill through the
intercondylar notch to access the medullary cavity. Then a
stainless steel Kirschner wire (1.1 mm diameter and 10 mm
in length) and a 14-mm long needle were placed into the
drill-made hole in the femur. A length of 4 mm of the distal
part of the needle was left exposed outside the knee joint
and bent at an angle of 90. A polyvinyl tube was connected
to the osmotic pump implanted in the right side of the back
and was led subcutaneously to the right knee joint,
whereas the other end of the polyvinyl tube was connected
to the exposed needle. The same operation was carried out
on the left limb (control side), but the pump implanted in
Infusion of UHMWPE particles by osmotic pumps 51the left side of the back contained only rat serum (Fig. 1).
After implant insertion, the quadricepsepatellar complex
was repositioned and the medial quadriceps arthrotomy
and dorsal incision for the pump were repaired with 5.0
vicryl sutures. Euthanasia was carried out in a CO2 chamber
6 weeks after surgery. All the femurs were harvested and
routinely fixed in 10% buffered formalin for histological,
immunohistochemical, and biomechanical fixation strength
evaluation.
Radiological examination
Radiographs were taken of each rat immediately following
surgery to confirm successful positioning of the implanted
rods. Radiographs were taken of each rat at the time of
sacrifice and were examined for evidence of endosteal
erosion, focal bone lysis, and trabecular bone loss. In
accordance with Park et al.’s study [14], the mean optical
density (MOD) was evaluated for each femur side using the
Image-Pro Plus 6.0 software package (Media Cybernetics,
Bethesda, MD, USA). The radiographs were compared for
osteolysis by three independent observers who were blind
to this study. Intraobserver variance was assessed by ana-
lysing the same radiographs three times and interobserver
variance was also assessed for each analysis.
Calculation of delivered particles
At the time of sacrifice the volume of and the particle
concentration in the suspension remaining in the retrieved
osmotic pumps was used to calculate the total number of
delivered particles during the whole of this 6-week
experiment.
Histological analysis
The formalin-fixed femurs were decalcified in a solution
containing 22% formic acid and 10% sodium citrate prior to
paraffin embedding. The sections were stained with hae-
matoxylin and eosin to examine new bone formation or
bone erosion around the prosthesis, and to evaluate debris-
associated periprosthetic tissue formation, including newFigure 1 Two osmotic pumps were implanted in the backs of
rats (left and right). The polyvinyl tubing connected with each
side of the pump was led subcutaneously to the knee joint and
connected to the exposed needle. A Kirschner wire and a
needle were placed into the drill hole in each femur.bone formation and interface membrane using an inverted
microscope. A polarising microscope was used for the
detection of UHMWPE particles.
Tartrate-resistant acid phosphatase staining for
osteoclasts
A commercial kit (SigmaeAldrich, St Louis, MO, USA) was
used for histological tartrate-resistant acid phosphatase
(TRAP) staining using paraffin-sectioned femurs after
prosthesis removal. Following deparaffinisation and rehy-
dration, the sections were permeated in a microwave oven
for 30 s prior to a brief fixation in buffered acetone. The
sections were then incubated at 37 C for 1 h in 0.1 M ac-
etate buffer (pH 5.2), containing 0.5 mM naphthol AS-BI
phosphoric acid, 2.2 mM Fast Garnet GBC, and 10 mM so-
dium tartrate. The reaction was stopped by washing in
several changes of distilled water. The presence of dark
purple staining granules in the cytoplasm was considered as
the specific criterion for identifying TRAP positive cells.
The levels of the positive stains and localizations were
evaluated in five different fields per section.
Receptor activator of nuclear factor-kB
immunohistochemical staining
Antibodies against receptor activator of nuclear factor-kB
(RANK; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
were applied according to the instructions of the antibody
vendors, using methods reported previously for immuno-
histochemistry [15]. In negative control sections, the pri-
mary antibody was replaced with appropriately diluted
irrelevant antisera. Digital images of IHC stained sections
were captured. The presence of brown staining granules in
the cytoderm was considered as the specific criterion for
identifying RANK-positive cells. The levels of the positive
stains and localizations were evaluated in five different
fields per section and expressed as integrated optical
density, using Image-Pro Plus 6.0 (Media Cybernetics
Manufacturing, Warrendale, PA, USA) [16].
Pull-out test
The prosthesis pull-out test was carried out using Autograph
AGS-J (Shimadzu, Tokyo, Japan) universal mechanical
tester. According to Dhert’s [17] method, a bracket with a
3.5 mm diameter hole was used in this study. The Kirschner
wire was pulled out of the femur at the mobile rate of
0.5 mm/min (first load began with 2 N) after the end of the
distal Kirschner wire was put into the 3.5 mm diameter
hole. The load-displacement curve was recorded and the
ultimate shear stress (the minimal load that made bone-
implant interface separate, N) was calculated during the
pull-out study.
Statistical analysis
The data from three independent experiments were ana-
lysed for this study. Paired t tests were performed on ani-
mals to compare the left and right femurs using SPSS
52 R.-f. Ma et al.version 18.0 (SPSS Inc., Chicago, IL, USA). A p value < 0.05
was considered significant. Data were expressed as
mean  standard deviation of the mean.
Results
Operative outcome
The rats tolerated the surgical procedure well and ambu-
lated with the implanted limb within 3 days after surgery.
The incisions healed with no complications and the sutures
were removed 10 days after surgery. No infections were
observed during the course of the experiment.Figure 2 A radiograph was taken of each rat immediately follow
correctly located in the medullary cavity of each distal femur.
radiograph was taken. (C) Irregular translucent areas were observ
treatment side. (D) Such changes were not observed in the contr
199.43  62.36, whereas that of the treatment side was 164.98 Radiographic study
Radiographs were taken of each rat immediately following
surgery. The radiographs showed that the implants were
correctly located in the medullary cavity of the distal
femurs (Fig. 2A). At the time of sacrifice, irregular
translucent areas were observed around the Kirschner
wire and the thinner cortical bone in the treatment side
after 6 weeks (Fig. 2B and C). However, such changes
were not observed in the control side (Fig. 2B and D). The
MOD of the control side was 199.43  62.36, whereas that
of the treatment side was 164.98  26.47 (p < 0.05;
Fig. 2E).ing surgery. (A) The radiographs show that the implants were
(B) At the time of sacrifice (6 weeks after surgery), another
ed around the prosthesis and the thinner cortical bone in the
ol side. (E) The mean optical density of the control side was
26.47. *p < 0.05.
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The particle concentration of each suspension and the
average remaining volume of suspension in the retrieved
osmotic pumps was 95  9 mL. The delivered volume was
105  9 mL (200e95Z 105 ml), and the delivered quantity of
UHMWPE particles was (5.25  0.45)  109.Histological analysis
Histological evaluation of the Kirschner wire prosthesis
model on haematoxylin and eosin sections clearly indicated
the proper location of the implant and new bone ingrowth
in each side of the femurs. The new bone in the treatment
side was thinner or interrupted and did not form a complete
ringed bone in comparison with that of the control side
(Fig. 3A and B). There was no or only a small amount ofFigure 3 (A) The new bone formed a complete ringed bone aroun
side, the new bone was thinner or interrupted and did not form a c
amount of interface membrane in the control side (400). (D) The
the new bone laterally, giving the new bone close to the inter
appearance (400). (E) In some areas of the interface membrane
bone marrow macrophages were observed (400). (F) UHMWPE par
bone could be seen under the polarizing microscope ( 100). Magninterface membrane in the control side, showing little of
the tissue cells and giant cells between the new bone and
the Kirschner wire prosthesis (Fig. 3C). In the treatment
side the local interface membrane was of varying thickness,
and had invaded the new bone laterally, with the result
that the new bone close to the interface membrane showed
an irregular depression with a worm-bitten appearance
(Fig. 3D). In some areas of the interface membrane
UHMWPE particles appeared in clusters and had been
phagocytized by bone marrow macrophages (Fig. 3E).
UHMWPE particles scattered beside the prosthesis and new
bone could be seen under a polarizing microscope (Fig. 3F).TRAP staining
TRAP staining was performed to identify mature osteoclasts
at the boneeimplant interface. There was a markedd the prosthesis in the control side (100). (B) In the treatment
omplete ringed bone (100). (C) There was no or only a small
treatment side produced an interface membrane that invaded
face membrane an irregular depression with a worm-eaten
clusters of UHMWPE particles that had been phagocytised by
ticles (white in colour) scattered beside the prosthesis and new
ification for the picture inset is 200 .
Figure 4 There was a marked reduction in tartrate-resistant acid phosphataseþ cells (11.1  2.5; A,C) in the control side in
comparison with (B,C) the treatment side (21.3  3.9). *p < 0.05. (B) Green arrows represent the tartrate-resistant acid phos-
phataseþ cells; magnification for inset is 400. The integrated optical density of receptor activator of nuclear factor-kBþ cells in
(D,F) the control side (9800.4  1553.6) was less than that of (E,F) the treatment side (32351.4  3916.3). *p < 0.05.
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4A and C) in comparison with the treatment side (21.3 
3.9, Fig. 4B and C). p < 0.05.
RANK staining
There was a marked reduction in RANKþ cells adjacent to
the bone cortex of the control side (Fig. 4D and F) in
comparison with the treatment side (Fig. 4E and F). The
integrated optical density of the treatment side (32351.4 
3916.3) was greater than that of the control side (9800.4 
1553.6). p < 0.05.Figure 5 (A) (B) The ultimate pull-out force was 1.14  0.08 N
*p < 0.05.Pull-out test
The pull-out force was 1.14  0.08 N in the control side and
0.66  0.14 N in the treatment side (p < 0.05; Fig. 5).Discussion
Our radiographic and histological findings suggest that
UHMWPE particles cause differing clinical outcomes be-
tween the treatment and control side. As is known from
other animal models, UHMWPE particles demonstrated toin the control side and 0.66  0.14 N in the treatment side.
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lucent area and weaker new bone formation showed
osteolysis on the treatment side. A lower pull-out force
during the pull-out test also indicated aseptic loosening on
the treatment side. These findings suggest that the self-
control continuous infusion rat model is an interesting and
valuable research tool for further in vivo studies. Ortiz
et al. [18] first demonstrated an infusion model in vitro and
in mice [19]. This in vivo infusion rate could be affected by
complex factors, such as animal activity, body tempera-
ture, and muscle contraction, and was different to the
results of the in vitro study [19]. If the treatment and
control procedures are carried out in different individual
animals, the comparability is reduced. Using this self-
control model, it is possible to compare treatmentetreat-
ment procedure and controlecontrol procedure in the same
rat and get more confirmed data.
Many significant findings of particle-induced osteolysis
were derived from classical mouse models as these models
are most frequently used [20,21], although rat models are
becoming more popular [22,23]. Although the mouse
models would facilitate future cellular and molecular
studies, there are some pitfalls: firstly, a mouse can only
carry one osmotic pump, therefore a self-control study,
which can greatly eliminate individual differences between
animals, is not possible; secondly, as the bone cortex of
mice femurs is rather thin [24], it is hard to detect
osteolysis using conventional radiographs and immunohis-
tochemistry; and thirdly, the soft tubing used in the study is
more easily pressed into the knee cavity, and this may in-
fluence the continuous infusion of submicron-sized parti-
cles. Furthermore, the bone-implant interface had no
contact with the synovial membrane of the knee cavity, and
the rod prosthesis was not able to withstand the circulating
load produced by joint movement [25].
We based our rat model on the models of Kim et al. [11],
Iwase et al. [26], and Ma et al. [27]. In the current study, the
volume of and the particle concentration in the suspension
remaining in each of the retrieved osmotic pumps were used
to calculate the total number of delivered particles. The rats
were able to carry two osmotic pumps for particle infusion
(control side: rat serum only; treatment side: UHMWPE-
particle suspension), which made it possible to perform a
self-control study to largely eliminate individual differences
between animals. The filling tubing in the knee joint cavity
was replaced by a metal needle, which could avoid collapse
and blockage of the filling tube, and the needle could also
bear the load of body weight transduced by femur and
simulate the weight-bearing effects [28]. Furthermore, the
bone-implant interface had contact with the synovial
membrane of the knee cavity, and the prosthesis was able to
withstand the circulating load produced by joint movement
and promote the proliferation of wear particles.
In the present study, all the treatment sides showed that
interface membrane tissue was produced, and some wear
particles that had been phagocytized by bone marrow
macrophages were observed in some areas of this interface
membrane. This phenomenon was not seen in the control
side. The radiographs showed a significant difference in the
MOD between the control and treatment sides. Ma et al.
[19], however, did not find an interface membrane around
the prosthesis using histological analyses, and radiographsshowed no difference between the UHMWPE-particle group
and the control group in their study. We speculated that the
difference in the extent of osteolysis in our study and Ma
et al.’s [19] study could be attributed to the difference in
the number of infusion particles and the infusion period.
This assumption was in line with that of Tipper et al.’s [29]
study. In the present study, the number of infused UHMWPE
particles was 5.25  109 (infusion rate: 0.15 mL/h, 6 weeks),
whereas the number of infused UHMWPE particles in Ma
et al.’s [19] study was 4.7  1010 (infusion rate: 0.25 ml/h, 4
weeks). Therefore, the present rat model showed a signif-
icant difference although the resolution of the radiographs
was much lower than that of microcomputed tomography
(microCT). Furthermore this model had the advantages of a
large-scale application.
TRAP is used to identify mature osteoclasts, and RANK is
the protein marker of osteoclasts and osteoclast precursor
cells [12,13]. As we had already confirmed that UHMWPE
particles can promote osteoclast precursor cells to trans-
form into osteoclasts in our previous in vitro studies
[12,13], the TRAP and RANK protein expression level was
calculated in this present study in order to verify the above
osteolysis phenomenon in vivo. The results reveal dimin-
ished TRAP positive stains and a reduction in the protein
expression levels of RANK in the control side compared with
the treatment side. These results are in agreement with our
previous in vitro studies. Finally, in order to test the
biomechanical fixation strength of the prosthesis after
continuous infusion of UHMWPE particles, we carried out a
pull-out study that produced results in line with our
radiological examination and histological study.
Although this study has given promising results, our
model can be further improved in some aspects. The
radiological, histological, and biomechanical findings have
strongly demonstrated that aseptic loosening took place on
the particle treated side. To validate and improve the an-
imal model we intend to use microCT, which provides a
better quantification of osteolysis than radiographs in
further studies [4]. The effects of particle size, concen-
tration, and infusion time will be studied in the future.
In conclusion, continuous infusion of UHMWPE particles
into the rat bone-implant interface simulated the clinical
scenario of local polymer wear-particle generation and de-
livery in humans. The main aim of the present study was to
determine the relationship between the amount of infused
wear debris and the extent of osteolysis. More accurate
measurement instruments, such as microCT, may be used for
precise determination of the extent of osteolysis in our
future study. The osmotic pump used in the present model
could also be used for continuous infusion of medicine to
eliminate osteolysis. This study has already been carried out.Conflicts of interests
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